Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Oritavancin Use In Recurrent Bone Infections by Methicillin-Resistant
Staphylococcus aureus
2
Mins
June 2024
Oritavancin is a novel long-acting lipoglycopeptide that is active against gram-positive micro-organisms, including…
Read more
1
Mins
19 Aug 2021
Be Conscious of
Cryptococcus neoformans
: Cryptococcal Meningoencephalitis and Cryptococcaemia with Unfavourable Outcome in a Patient with Myasthenia Gravis
Cryptococcus neoformans is an opportunistic fungal pathogen transmitted to humans by inhalation, mainly of infected bird…
2
Mins
19 Aug 2021
A Single-Centre Retrospective Study on the Impact of Reducing Surgical Prophylaxis from 48 hours to 24 hours in Cardiovascular Surgery
There is limited evidence to guide duration of antibiotic prophylaxis in cardiovascular surgeries. While available evidence and guidelines…
1
Mins
19 Aug 2021
Evaluation of Vaccination Effectiveness Against SARS-CoV-2 in Healthcare Professionals
The COVID-19 pandemic is an ongoing global pandemic that is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)…
2
Mins
19 Aug 2021
Direct Linkage Between the Prevalence of Known Common Extra-intestinal Pathogenic Escherichia coli Sequence Types in UK Sewage to Those Causing E. coli Urinary Tract Infections and Sepsis
Escherichia coli are a hugely diverse group of bacteria that include harmless commensals as well as virulent pathogens…
2
Mins
19 Aug 2021
Aspergillus Sensitisation in Patients with Severe Asthma
Asthma is a chronic inflammatory disease of the respiratory tract and a serious global medical and social problem.1 It is known that…
1
Mins
19 Aug 2021
Do Infections Start in the Gut? Patients with Inflammatory Bowel Disease Have a Higher Risk of Periprosthetic Joint Infection after Surgery
A large body of evidence is emerging to implicate that dysregulation of the gut microbiome (dysbiosis) increases the risk of surgical…
1
Mins
19 Aug 2021
Plasma-Activated Water as a New Weapon Against Multidrug-Resistant Bacteria
Multidrug-resistant (MDR) bacteria, or ‘superbugs’, pose an impending threat for human health around the world. Common infections are…
1
Mins
1 Jun 2020
The Case for Pharmacokinetic/ Pharmacodynamic Studies During Epidemics of High Consequence Pathogens: Tekmira For Ebola Virus Disease in Sierra Leone
Pharmacokinetic/pharmacodynamic (PK/PD) studies during epidemics pose substantial logistical and safety challenges. However, the data generated can be…
Loading posts...
« Previous
1
2
3
4
Next »